We are actively cooperating with researchers and third-party platforms engaged in COVID-19 research and treatment development. We will continue to provide high-quality products, services, consultation and a high level of responsiveness to support the research and development of new coronaviruses worldwide.
We support this vital research by providing the following solutions.
COVID-19 Resources & News
Will the mRNA vaccine become the “savior” of COVID-19?
Cell Immunity: SARS-CoV-2 vaccines status
bioRxiv.: Scientists Find siRNA drugs that may inhibit SARS-CoV-2